Romosozumab
ATC M05BX06 · 10 markets · 15 records
AU 4 records · 3 strengths
- 105 mg/1.17 mLinjectionEvenity
- 105 mginjectionEVENITY romosozumab 105 mg/1.17 mL injection solution syringeEVENITY romosozumab 105 mg/1.17 mL injection solution syringe with a pen injector
Records without a stated strength · 1 Evenity
US 3 records · 1 strengths
- 105 mg/1.17 mLinjectionEvenity
GB 1 records · 1 strengths
- 105 mg/1.17 mLinjectionEvenity 105mg/1.17ml solution for injection pre-filled pens
CA 1 records · 1 strengths
- 89.74359 mg/1 mLliquidEvenity
SG 1 records · 1 strengths
- 105 mg/1.17 mLinjectionEVENITY SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 105 MG/1.17 ML
ES 1 records · 1 strengths
- 105 mginjectionEVENITY PRECARGADA
MX 1 records · 1 strengths
Records without a stated strength · 1 Evenity
TW 1 records · 1 strengths
Records without a stated strength · 1 EVENITY Solution for Injection、益穩挺 注射液
HK 1 records · 1 strengths
Records without a stated strength · 1 EVENITY SOLUTION FOR INJECTION IN PREFILLED SYRINGE 105MG/1.17ML
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Evenity
| Strength / form / release | US | GB | CA | AU | SG | ES | MX | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|---|---|
| 105 mg/1.17 mL injection | Evenity | Evenity 105mg/1.17ml solution for injection pre-filled pens | Evenity | EVENITY SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 105 MG/1.17 ML | ||||||
| 105 mg injection | EVENITY romosozumab 105 mg/1.17 mL injection solution syringe EVENITY romosozumab 105 mg/1.17 mL injection solution syringe with a pen injector | EVENITY PRECARGADA | ||||||||
| 89.74359 mg/1 mL liquid | Evenity | |||||||||
unknown | Evenity | EVENITY SOLUTION FOR INJECTION IN PREFILLED SYRINGE 105MG/1.17ML | Evenity | |||||||
injection | EVENITY Solution for 益穩挺 | |||||||||
liquid | Evenity |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
2 more strength/form rows are recorded only in CA · MX and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en CA · MX que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 CA · MX 有记录(未在本表显示)。 另有 2 個規格/劑型僅在 CA · MX 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.